Comprehensive Stock Comparison
Compare Syra Health Corp. Class A Common Stock (SYRA) vs AMN Healthcare Services, Inc. (AMN) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SYRA | 44.7% revenue growth vs AMN's -21.3% |
| Quality / Margins | AMN | -3.5% net margin vs SYRA's -16.9% |
| Stability / Safety | SYRA | Beta 0.78 vs AMN's 1.00, lower leverage |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | AMN | -23.1% vs SYRA's -75.3% |
| Efficiency (ROA) | AMN | -4.6% ROA vs SYRA's -38.8%, ROIC -3.9% vs -294.7% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Syra Health is a healthcare services company that provides health education, population health management, behavioral health, workforce solutions, and digital health services. It generates revenue through service contracts with government agencies, health networks, and pharmaceutical manufacturers — primarily from its health education and population health management segments. The company's competitive advantage lies in its integrated service portfolio addressing multiple healthcare system pain points, including its Syrenity telehealth platform for mental health services.
AMN Healthcare is a leading healthcare staffing and workforce solutions company that connects healthcare facilities with temporary and permanent medical professionals. It generates revenue primarily through staffing services—with nurse and allied staffing making up the largest segment—alongside physician placement and technology-enabled workforce management solutions. The company's scale, extensive network of healthcare professionals, and established relationships with thousands of healthcare facilities create significant barriers to entry for competitors.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
AMN leads in 3 of 6 categories (Financial Metrics, Profitability & Efficiency). SYRA leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
AMN is the larger business by revenue, generating $2.7B annually — 364.1x SYRA's $7M. AMN is the more profitable business, keeping -3.5% of every revenue dollar as net income compared to SYRA's -16.9%. On growth, AMN holds the edge at +1.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| RevenueTrailing 12 months | $7M | $2.7B |
| EBITDAEarnings before interest/tax | -$1M | $25M |
| Net IncomeAfter-tax profit | -$1M | -$96M |
| Free Cash FlowCash after capex | -$231,031 | $242M |
| Gross MarginGross profit ÷ Revenue | +31.4% | +28.3% |
| Operating MarginEBIT ÷ Revenue | -16.9% | -2.0% |
| Net MarginNet income ÷ Revenue | -16.9% | -3.5% |
| FCF MarginFCF ÷ Revenue | -3.1% | +8.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -25.1% | +1.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +67.1% | +95.9% |
Valuation Metrics
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| Market CapShares × price | $60,000 | $987M |
| Enterprise ValueMkt cap + debt − cash | -$2M | $2.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.19x | -5.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 29.18x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 0.33x |
| Price / BookPrice ÷ Book value/share | 0.25x | 1.05x |
| Price / FCFMarket cap ÷ FCF | — | 4.12x |
Profitability & Efficiency
AMN delivers a -14.9% return on equity — every $100 of shareholder capital generates $-15 in annual profit, vs $-57 for SYRA. SYRA carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.55x. On the Piotroski fundamental quality scale (0–9), AMN scores 4/9 vs SYRA's 3/9, reflecting mixed financial health.
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| ROE (TTM)Return on equity | -57.3% | -14.9% |
| ROA (TTM)Return on assets | -38.8% | -4.6% |
| ROICReturn on invested capital | -2.9% | -3.9% |
| ROCEReturn on capital employed | -106.4% | -5.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.16x | 1.55x |
| Net DebtTotal debt minus cash | -$2M | $1.1B |
| Cash & Equiv.Liquid assets | $2M | $11M |
| Total DebtShort + long-term debt | $452,077 | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | -99.37x | -1.39x |
Total Returns (with DRIP)
A $10,000 investment in AMN five years ago would be worth $2,553 today (with dividends reinvested), compared to $333 for SYRA. Over the past 12 months, AMN leads with a -23.1% total return vs SYRA's -75.3%. The 3-year compound annual growth rate (CAGR) favors AMN at -40.0% vs SYRA's -67.8% — a key indicator of consistent wealth creation.
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| YTD ReturnYear-to-date | +14.9% | +28.8% |
| 1-Year ReturnPast 12 months | -75.3% | -23.1% |
| 3-Year ReturnCumulative with dividends | -96.7% | -78.4% |
| 5-Year ReturnCumulative with dividends | -96.7% | -74.5% |
| 10-Year ReturnCumulative with dividends | -96.7% | -31.5% |
| CAGR (3Y)Annualised 3-year return | -67.8% | -40.0% |
Risk & Volatility
SYRA is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than AMN's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 71.7% from its 52-week high vs SYRA's 24.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 1.00x |
| 52-Week HighHighest price in past year | $0.41 | $27.17 |
| 52-Week LowLowest price in past year | $0.03 | $14.87 |
| % of 52W HighCurrent price vs 52-week peak | +24.4% | +71.7% |
| RSI (14)Momentum oscillator 0–100 | 51.5 | 50.8 |
| Avg Volume (50D)Average daily shares traded | 12K | 1.1M |
Analyst Outlook
| Metric | SYRASyra Health Corp.… | AMNAMN Healthcare Se… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $22.88 |
| # AnalystsCovering analysts | — | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Sep 23 | Feb 26 | Change |
|---|---|---|---|
| Syra Health Corp. C… (SYRA) | 100 | 2.67 | -97.3% |
| AMN Healthcare Serv… (AMN) | 100 | 25.68 | -74.3% |
AMN Healthcare Serv… (AMN) returned -74% over 5 years vs Syra Health Corp. C… (SYRA)'s -97%.
Chart 2Revenue Growth — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Syra Health Corp. C… (SYRA) | $0.00 | $8M | — |
| AMN Healthcare Serv… (AMN) | $1.5B | $3.0B | +103.9% |
AMN Healthcare Services, Inc.'s revenue grew from $1.5B (2015) to $3.0B (2024) — a 8.2% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Syra Health Corp. C… (SYRA) | -0.2% | -47.1% | -20147.6% |
| AMN Healthcare Serv… (AMN) | 5.6% | -4.9% | -188.0% |
AMN Healthcare Services, Inc.'s net margin went from 6% (2015) to -5% (2024).
Chart 4P/E Ratio History — 7 Years
| Stock | 2017 | 2023 | Change |
|---|---|---|---|
| AMN Healthcare Serv… (AMN) | 18.4 | 14 | -23.9% |
AMN Healthcare Services, Inc. has traded in a 10x–46x P/E range over 7 years; current trailing P/E is ~-5x.
Chart 5EPS Growth — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Syra Health Corp. C… (SYRA) | -0 | -0.52 | -74185.7% |
| AMN Healthcare Serv… (AMN) | 1.68 | -3.85 | -329.2% |
AMN Healthcare Services, Inc.'s EPS grew from $1.68 (2015) to $-3.85 (2024) — a NaN% CAGR.
Chart 6Free Cash Flow — 5 Years
Syra Health Corp. Class A Common Stock generated $-3M FCF in 2024 (-3015% vs 2021). AMN Healthcare Services, Inc. generated $240M FCF in 2024 (-5% vs 2021).
SYRA vs AMN: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is SYRA or AMN a better buy right now?
Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SYRA or AMN?
Over the past 5 years, AMN Healthcare Services, Inc. (AMN) delivered a total return of -74.5%, compared to -96.7% for Syra Health Corp. Class A Common Stock (SYRA). A $10,000 investment in AMN five years ago would be worth approximately $3K today (assuming dividends reinvested). Over 10 years, the gap is even starker: AMN returned -31.5% versus SYRA's -96.7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SYRA or AMN?
By beta (market sensitivity over 5 years), Syra Health Corp. Class A Common Stock (SYRA) is the lower-risk stock at 0.78β versus AMN Healthcare Services, Inc.'s 1.00β — meaning AMN is approximately 28% more volatile than SYRA relative to the S&P 500. On balance sheet safety, Syra Health Corp. Class A Common Stock (SYRA) carries a lower debt/equity ratio of 16% versus 155% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
04Which has better profit margins — SYRA or AMN?
AMN Healthcare Services, Inc. (AMN) is the more profitable company, earning -4.9% net margin versus -47.1% for Syra Health Corp. Class A Common Stock — meaning it keeps -4.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMN leads at -3.4% versus -47.2% for SYRA. At the gross margin level — before operating expenses — AMN leads at 30.8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — SYRA or AMN?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is SYRA or AMN better for a retirement portfolio?
For long-horizon retirement investors, Syra Health Corp. Class A Common Stock (SYRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.78)). Both have compounded well over 10 years (SYRA: -96.7%, AMN: -31.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between SYRA and AMN?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.